Rheumatology Vol. 44 No. 1 © British Society for Rheumatology 2005; all rights reserved
LETTER TO THE EDITOR |
Weekly alendronate-induced acute pseudogout
1 Newcastle Musculoskeletal Research Group, Level 4, Cookson Building, University of Newcastle-upon-Tyne, Framlington Place, NE2 4HH, 2 Department of Rheumatology and 3 Pharmacy, The James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW, UK.
Correspondence to: S. Young-Min, Newcastle Musculoskeletal Research Group, Level 4, Cookson Building, University of Newcastle-upon-Tyne, Framlington Place, NE2 4HH, UK. E-mail: Steven.YoungMin@ncl.ac.uk
| The first 10% of the full text of this article appears below. |
SIR, A 47-yr-old nursery nurse with a history of chronic asthma and bilateral knee osteoarthritis sustained three low-trauma fractures over a period of 3 yr. After investigation, she was diagnosed with osteoporosis and commenced on weekly alendronate 70 mg. A few hours after her first dose,